Biological principles and clinical application of positron emission tomography-tracers in prostate cancer: a review

@article{Rocha2019BiologicalPA,
  title={Biological principles and clinical application of positron emission tomography-tracers in prostate cancer: a review},
  author={Jos{\'e} M. Machado Rocha and Bruno Jorge Pereira},
  journal={Prostate International},
  year={2019},
  volume={7},
  pages={41 - 46}
}
  • José M. Machado Rocha, Bruno Jorge Pereira
  • Published 2019
  • Medicine
  • Prostate International
  • Prostate carcinoma is the most common malignancy in men and the second cause of death by cancer in the western world. Currently, prostate carcinoma's diagnosis is achieved by transrectal ultrasound-guided biopsy (gold-standard), usually requested after an elevation of prostate specific antigen (PSA) levels or an abnormal digital rectal exam or transrectal ultrasound. Nevertheless, this diagnosis sequence sometimes presents with significant limitations. Therefore, there is a need of a diagnosis… CONTINUE READING

    References

    SHOWING 1-10 OF 36 REFERENCES
    PSMA PET and Radionuclide Therapy in Prostate Cancer.
    • 51
    PET Tracers Beyond FDG in Prostate Cancer.
    • 46
    • PDF
    Prostate Cancer Imaging with Novel PET Tracers
    • 40
    The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    • 720
    • PDF
    11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation
    • 112
    • PDF